ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,827.04
-1.54%
Dow Jones
41,938.45
-1.63%
US Dollar vs MXN
20.77385
0.30%
Brent Oil
80.645
0.04%
Bitcoin
94,145.67
-0.36%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC

  6. Retinalgenix Technologies Inc (QB) (RTGN) Cotización

Retinalgenix Technologies Inc (QB)

Retinalgenix Technologies Inc (QB) (RTGN)

USOTC
6.36
0.00
(0.00%)
Cerrado 12 Enero 3:00PM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
6.36
Postura de Compra
1.62
Postura de Venta
54.00
Volume Operado de la Acción
30
0.00 Rango del Día 0.00
0.25 Rango de 52 semanas 6.36
Capitalización de Mercado [m]
115.057M
Precio Anterior
6.36
Precio de Apertura
-
Hora
30
@
53
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
333
Acciones en circulación
18,090,739
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-55.02
Beneficio por acción (BPA)
-0.12
turnover
-
Beneficio neto
-2.09M

Acerca de Retinalgenix Technologies Inc (QB)

Retinalgenix Technologies Inc now including DNA?GPS is an R&D Ophthalmic and genetic mapping software development company based in Petaluma California. Its core is in EYECARE Imagining, patient home monitoring and in .pharmaco -mapping patient software App Retinalgenix Technologies Inc now including DNA?GPS is an R&D Ophthalmic and genetic mapping software development company based in Petaluma California. Its core is in EYECARE Imagining, patient home monitoring and in .pharmaco -mapping patient software App

Sector
Surgical,med Instr,apparatus
Industria
Surgical,med Instr,apparatus
Sitio web
www.retinalgenix.com.
Sede
Lewes, Delaware, USA
Fundado
-
Retinalgenix Technologies Inc (QB) is listed in the Surgical,med Instr,apparatus sector of the OTCMarkets with ticker RTGN. The last closing price for Retinalgenix Technologies (QB) was US$6.36. Over the last year, Retinalgenix Technologies (QB) shares have traded in a share price range of US$ 0.25 to US$ 6.36.

Retinalgenix Technologies (QB) currently has 18,090,739 shares in issue. The market capitalisation of Retinalgenix Technologies (QB) is US$115.06 million. Retinalgenix Technologies (QB) has a price to earnings ratio (PE ratio) of -55.02.

RTGN Últimas noticias

Más noticias

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

18 Noviembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

19 Agosto 2024
Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

14 Agosto 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

20 Mayo 2024
Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

16 Mayo 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

12 Mayo 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

12 Mayo 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

12 Febrero 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

12 Febrero 2024
Edgar (US Regulatory)

Form D - Notice of Exempt Offering of Securities

09 Febrero 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.5810.03460207615.786.363.75006.36CS
41.1121.14285714295.256.363.73006.175CS
124.76297.51.66.360.253334.345CS
262.8681.71428571433.56.360.252004.345CS
523.26105.1612903233.16.360.251504.03666667CS
1563.361123200.251566.2996991CS
2603.361123200.251566.2996991CS

RTGN - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Retinalgenix Technologies (QB)?
El precio actual de las acciones de Retinalgenix Technologies (QB) es US$ 6.36
¿Cuántas acciones de Retinalgenix Technologies (QB) están en circulación?
Retinalgenix Technologies (QB) tiene 18,090,739 acciones en circulación
¿Cuál es la capitalización de mercado de Retinalgenix Technologies (QB)?
La capitalización de mercado de Retinalgenix Technologies (QB) es USD 115.06M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Retinalgenix Technologies (QB)?
Retinalgenix Technologies (QB) ha negociado en un rango de US$ 0.25 a US$ 6.36 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Retinalgenix Technologies (QB)?
El ratio precio/beneficio de Retinalgenix Technologies (QB) es -55.02
¿Cuál es la moneda de reporte de Retinalgenix Technologies (QB)?
Retinalgenix Technologies (QB) presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Retinalgenix Technologies (QB)?
El último beneficio anual de Retinalgenix Technologies (QB) es USD -2.09M
¿Cuál es la dirección registrada de Retinalgenix Technologies (QB)?
La dirección registrada de Retinalgenix Technologies (QB) es 16192 COASTAL HWY, LEWES, DELAWARE, 19958
¿Cuál es la dirección del sitio web de Retinalgenix Technologies (QB)?
La dirección del sitio web de Retinalgenix Technologies (QB) es www.retinalgenix.com.
¿En qué sector industrial opera Retinalgenix Technologies (QB)?
Retinalgenix Technologies (QB) opera en el sector SURGICAL,MED INSTR,APPARATUS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
CRGPCalissio Resources Group Inc (CE)
US$ 0.0004
(39,900.00%)
20k
SMMESmartMetric Inc (PK)
US$ 0.0001
(9,900.00%)
1.25M
NEOMNeoMedia Technologies Inc (CE)
US$ 0.0001
(9,900.00%)
534.97k
RRGIReality Racing Inc (CE)
US$ 0.0001
(9,900.00%)
209k
ELIQQElectriq Power Holdings Inc (CE)
US$ 0.0001
(9,900.00%)
290
IBKKFImining Technologies Inc (CE)
US$ 0.000001
(-100.00%)
100
EGIOQEdgio Inc (CE)
US$ 0.000001
(-99.99%)
905
CYBFCyberfort Software Inc (CE)
US$ 0.000001
(-99.88%)
20k
CHMJDWaverunner Capital Inc
 0.0045
(-99.40%)
106
CCTLCoin Citadel (PK)
US$ 0.000001
(-99.00%)
108k
HMBLHUMBL Inc (PK)
US$ 0.0009
(0.00%)
359.72M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.00015
(50.00%)
194.9M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.00375
(-1.32%)
188.36M
TSOITherapeutic Solutions International Inc (PK)
US$ 0.0002
(-33.33%)
168.26M
PHILPHI Group Inc (PK)
US$ 0.00025
(-16.67%)
129.87M

Discusión

Ver feed completo
axelvento axelvento 3 minutos hace
has announced that it will be paying its dividend of $0.43 on the 7th of March, an increased payment from last year's comparable dividend. This makes the dividend yield 6.5%, which is above the industry average

$PFE
PFE
Steady_T Steady_T 5 minutos hace
You might be correct about the size of the GBM market in the UK. However you are missing the point.

Approval in the UK validates the MOA and the potential of treating other solid cancers. That will have much more impact than the limited size of the UK market.

Approval
NWBO
skitahoe skitahoe 5 minutos hace
While I'd love you to be right, that would represent over a $14 billion market cap, I believe that's high until the EDEN is available for production of the vaccine. I just don't believe that enough vaccine can be produced in Sawston to justify that market cap until they can make more, which require
NWBO
Saving Grace Saving Grace 6 minutos hace
Putz: We are not at 2 years. Who's we? LoL SMH

Keep an eye on the door. Big revelation! It's coming. UK
NB
elks elks 6 minutos hace
Thanks.
RDAR
commdude commdude 7 minutos hace
I purchased some MJLink stocks a few years ago via their web portal. I assume they are pretty much worthless now, or????  

It wasn't a large investment, and just crossed my mind that I have them after revisiting this forum.
WDLF
TradingCharts TradingCharts 9 minutos hace
Page 2 Signed July 26, 2024

https://cases.stretto.com/public/X063/10210/PLEADINGS/1021007262480000000235.pdf
7. Stalking Horse. The Trustee has demonstrated a sound business justification for
the Court to approve (i) Meteor Energy, LLC or its designee as the Stalking
IBATF
Steady_T Steady_T 12 minutos hace
Good article with a positive slant. It did touch on the potential negatives to give some balance.

Hopefully that is enough depth to generate some interest in Anavex. He did make clear that the approval is likely to be late in the year.

At this point I see a lot of vola
AVXL
axelvento axelvento 12 minutos hace
Why Is There No Vaccine For Norovirus As It Spreads Across US? How Much Do You Need To Wait ?
Among the most promising is the vaccine candidate from Moderna—currently being tested in human participants, says Health.com

https://www.timesnownews.com/health/why-is-there-no-vaccine
MRNA
Oleblue Oleblue 13 minutos hace
D-Wave Announces 2024 Bookings and First On-Premise Advantage System Sale

Capital Markets, Quantum Computing Business

Cierra Choucair
January 10, 2025

D-Wave Quantum Inc. reported fiscal year 2024 bookings exceeding $23 million, a
QBTS
fuagf fuagf 13 minutos hace
You have to be right, when it comes to money and power Musk has everything Trump wants. Wondering what Bannon could have up his sleeve, going out on a limb about keeping Musk out of the White House as he did. Just fell asleep for some two hours. Good break, but always feel lousy after.
Eli-316 Eli-316 15 minutos hace
Oh....around .02.
Very frustrating that we are where we are. But it coming. 
CGAC
Elroy Jetson Elroy Jetson 16 minutos hace
As Fire Investigators try to determine the cause of the Eaton fire that's burned 7,000 structures around Altadena, they keep returning to one place: an SCE electrical transmission tower in Eaton Canyon.

The once-lush hillside has been charred by flames spread by intense winds from
GonjaRelaxation GonjaRelaxation 16 minutos hace
Well seems to be several people snatching up the shares. Don't think price stays below a penny for long.
VDRM
axelvento axelvento 17 minutos hace
so it seems
PFE
axelvento axelvento 20 minutos hace
How close are we to a norovirus vaccine?
A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year

https://theweek.com/health/norovirus-vaccine-progress-moderna-science-health
MRNA
BIG D 4 BIG D 4 22 minutos hace
GO SAVING GRACE !! # 1 GAL HERE !! WELL -- why do you lower yourself to answer the 2 =1 nay sayers who are lost in lulu land ??? with worthless coments ? i never read their b s !! ignore is so great !! thanks s grace for great posts !! alfa and omega sounds biblical !! new golden age for us some day
MJNA
Jackxkr Jackxkr 23 minutos hace
If approved and nice, what is the share price, i have to thibk well over 10 bucks
NWBO
devil dog 96 devil dog 96 25 minutos hace
I was real lucky to find her when I did. It was earlier then 4 years ago. I'm one of the left overs from the 2016 to 2018 mega runs we all banked off of here when only management was marketing her back then. 🤑 This is my first post on this board for proof https://investorshub.advfn.com/board
ATMH

Su Consulta Reciente

USOTC
RTGN
Retinalgenix Technologies (QB)
TSX
GEI.R
Gibson Energy
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados